is tirzepatide a compounded semaglutide FDA sets compounding deadlines as shortage ends Concerns Surrounding Compounded GLP-1s Mount
Description
PMCID: PMC6484814
J Am Heart Assoc 10:e022930 Kolata G
The study shows that people who dosed as little as once every two months maintained weight loss and other improved health markers
However, patients with significant insulin resistance, Type 2 diabetes, or BMI-related comorbidities may require clinical assessment to determine whether pharmaceutical GLP-1 agonists or other interventions provide safer, more effective metabolic control
Wound Repair and Regeneration, 24 (2), 337348
